Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

Molecular identification, clinical assessment, characterization of SARS-CoV-2 RT-PCR results: Insights into twenty-one months of COVID-19 pandemic in a single center in Bangladesh

Breadcrumb

  • Home
  • Molecular identification, clinical assessment, characterization of SARS-CoV-2 RT-PCR results: Insights into twenty-one months of COVID-19 pandemic in a single center in Bangladesh

Toufiqul Islam 1, Arifa Akram 2, *, Md. Ashiqur Rahman 1, MD. Mahbub Ali 1, Md. Raihanul Islam 1, MD. Saif Uddin 1, Uttom Kumar Bhowmik 1, K. M. Ashik Elahi 3 and Md Alimur Reza 3

1 Department of Molecular, Novus Clinical Research Services Limited (NCRSL), Dhaka, Bangladesh.
2 Lab in Charge, Department of Molecular, Novus Clinical Research Services Limited (NCRSL), Dhaka, Bangladesh.
3 Department of Medical Affairs, Beximco Pharmaceuticals Ltd, Dhaka, Bangladesh.
 

Research Article
 
World Journal of Biology Pharmacy and Health Sciences, 2022, 12(03), 160–169.
Article DOI: 10.30574/wjbphs.2022.12.3.0234
DOI url: https://doi.org/10.30574/wjbphs.2022.12.3.0234

Received on 27 October 2022; revised on 09 December 2022; accepted on 12 December 2022

Introduction: The pervasiveness of SARS-CoV-2 infection over millions of people renders a variety of symptoms among group of people and ages. This study aimed to appraise the clinical assessment, characterization, and comparative study on suspected SARS-CoV-2 infected patients and further illuminate its transmission dynamics.
Methods: It includes all the suspected SARS-CoV-2 infected cases from July 2020 to March 2022 in this retrospective single center study. All the cases confirmed by the golden method of detection (real-time RT-PCR) and analyzed for clinical and demographic features and laboratory data.
Result: Out of 35,630 cases, 11.4% cases confirmed with SARS-CoV-2 infection. With 91.4% new and 8.6% follow-up suspected cases in total, SARS-CoV-2 infection confirmed with 85.5% new cases and 14.5% from follow-up cases. 86.1% male suspected cases found where SARS-CoV-2 infection confirmed for 73.8% with this gender group. 56.7% SARS-CoV-2 infection confirmed for age range 20-39 and this age group counts 59.3% from the total suspected cases. Most confirmed cases (28.3%) counted from Uttara, Dhaka and this area covers 34.9% suspected cases from the total.
Conclusion: This study exhibited that, SARS-CoV-2 is more prone to male individual, individuals aged between 20-39 and occurs re infection hardly but not limited to. Symptoms observed for almost half of the confirmed cases.

SARS-CoV-2; COVID-19 in Bangladesh; Pandemic; Clinical assessment, Characterization; Symptomatic; Asymptomatic; RT-PCR results

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2022-0234.pdf

Get Your e Certificate of Publication using below link

Download Certificate

Preview Article PDF

Toufiqul Islam, Arifa Akram, Md. Ashiqur Rahman, MD. Mahbub Ali, Md. Raihanul Islam, MD. Saif Uddin, Uttom Kumar Bhowmik, K. M. Ashik Elahi and Md Alimur Reza. Molecular identification, clinical assessment, characterization of SARS-CoV-2 RT-PCR results: Insights into twenty-one months of COVID-19 pandemic in a single center in Bangladesh. World Journal of Biology Pharmacy and Health Sciences, 2022, 12(03), 160–169. Article DOI: https://doi.org/10.30574/wjbphs.2022.12.3.0234

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution